Sartorius Aktiengesellschaft - SARTF Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$290.00
+0 (0.00%)

This chart shows the closing price for SARTF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Sartorius Aktiengesellschaft Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SARTF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SARTF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Sartorius Aktiengesellschaft in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $290.00.

This chart shows the closing price for SARTF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 1 investment analysts is to hold stock in Sartorius Aktiengesellschaft. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/24/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/22/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/22/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/21/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/19/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/17/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/17/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/16/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/22/2023Morgan StanleyDowngradeOverweight ➝ Equal Weight
1/27/2023Berenberg BankDowngradeBuy ➝ Hold
1/23/2023Credit Suisse GroupInitiated CoverageNeutral
10/24/2022Deutsche Bank AktiengesellschaftBoost TargetBuy ➝ Buy€531.00 ➝ €540.00
6/22/2022HSBCInitiated CoverageHold
5/16/2022UBS GroupUpgradeNeutral ➝ Buy
4/13/2022Berenberg BankUpgradeHold ➝ Buy
4/8/2022UBS GroupUpgradeSell ➝ Neutral
1/28/2022Societe GeneraleUpgradeHold ➝ Buy
11/11/2021UBS GroupReiterated RatingSell
10/13/2021CheuvreuxUpgradeReduce ➝ Hold
9/30/2021Societe GeneraleDowngradeBuy ➝ Hold
7/27/2021Societe GeneraleReiterated RatingBuy
7/6/2021AlphaValueUpgradeReduce
5/26/2021DZ BankReiterated RatingNeutral
5/25/2021Societe GeneraleUpgradeHold ➝ Buy
3/18/2021DZ BankReiterated RatingNeutral
2/10/2021DZ BankReiterated RatingSell
2/1/2021Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy
11/10/2020KeyCorpInitiated CoverageSector Weight
10/22/2020DZ BankReiterated RatingSell
10/20/2020JPMorgan Chase & Co.Reiterated RatingBuy
9/28/2020Berenberg BankReiterated RatingHold
9/25/2020JPMorgan Chase & Co.Reiterated RatingBuy
7/24/2020DZ BankReiterated RatingSell
7/21/2020JPMorgan Chase & Co.Reiterated RatingBuy
6/8/2020UBS GroupDowngradeNeutral ➝ Sell
4/24/2020DZ BankReiterated RatingSell
2/5/2020DZ BankReiterated RatingSell
11/22/2019DZ BankReiterated RatingSell
10/22/2019DZ BankReiterated RatingSell
7/19/2019DZ BankReiterated RatingSell
5/15/2019DZ BankReiterated RatingSell
(Data available from 4/16/2019 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/19/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/19/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/18/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/18/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/17/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/16/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/17/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/16/2024

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Sartorius Aktiengesellschaft logo
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products. In addition, the company offers water purification systems; surface plasmon resonance; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, equipment manufacturer cells, weights and weight sets, paint mixing solutions, and weighing accessories; and process filtration. Further, the company provides bioprocess consulting and engineering, biologics testing, media and process, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, pharmaceutical quality control, cell and gene therapy, and applied industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Göttingen, Germany.
Read More

Today's Range

Now: $290.00
Low: $290.00
High: $290.00

50 Day Range

MA: $294.94
Low: $286.27
High: $309.04

52 Week Range

Now: $290.00
Low: $198.00
High: $364.00

Volume

N/A

Average Volume

6 shs

Market Capitalization

N/A

P/E Ratio

89.51

Dividend Yield

N/A

Beta

0.93

Frequently Asked Questions

What sell-side analysts currently cover shares of Sartorius Aktiengesellschaft?

The following Wall Street analysts have issued stock ratings on Sartorius Aktiengesellschaft in the last year: Morgan Stanley.
View the latest analyst ratings for SARTF.

What is the current price target for Sartorius Aktiengesellschaft?

0 Wall Street analysts have set twelve-month price targets for Sartorius Aktiengesellschaft in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Sartorius Aktiengesellschaft in the next year.
View the latest price targets for SARTF.

What is the current consensus analyst rating for Sartorius Aktiengesellschaft?

Sartorius Aktiengesellschaft currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in SARTF, but not buy more shares or sell existing shares.
View the latest ratings for SARTF.

What other companies compete with Sartorius Aktiengesellschaft?

How do I contact Sartorius Aktiengesellschaft's investor relations team?

Sartorius Aktiengesellschaft's physical mailing address is OTTO-BRENNER-STRASSE 20, GOETTINGEN 2M, 37079. The company's listed phone number is 495513080 and its investor relations email address is [email protected]. The official website for Sartorius Aktiengesellschaft is www.sartorius.com. Learn More about contacing Sartorius Aktiengesellschaft investor relations.